{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T07:25:33Z","timestamp":1774423533654,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010104","name":"Tianjin Medical University","doi-asserted-by":"publisher","award":["2023-1-20"],"award-info":[{"award-number":["2023-1-20"]}],"id":[{"id":"10.13039\/501100010104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.radonc.2025.110781","type":"journal-article","created":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T09:52:04Z","timestamp":1739094724000},"page":"110781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Risk-adapted stereotactic body radiation therapy for the treatment of large (>3\u00a0cm) primary lung cancer with or without histologic confirmation: A propensity score matched and weighted analysis"],"prefix":"10.1016","volume":"205","author":[{"given":"Hong-Yu","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Zhi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan-Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Ru","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Yuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas G","family":"Zaorsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Ming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Yao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Chun","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Yong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-Bin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.110781_b0005","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2025.110781_b0010","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jtho.2022.08.011","article-title":"Stage migration and lung cancer incidence after initiation of low-dose computed tomography screening","volume":"17","author":"Vachani","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2025.110781_b0015","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/cac2.12359","article-title":"Non-small cell lung cancer in China","volume":"42","author":"Chen","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.radonc.2025.110781_b0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","article-title":"Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"22","author":"Riely","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.radonc.2025.110781_b0025","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.12-2359","article-title":"Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Howington","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.radonc.2025.110781_b0030","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/JTO.0b013e31817c9230","article-title":"Turning gray: the natural history of lung cancer over time","volume":"3","author":"Detterbeck","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2025.110781_b0035","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ijrobp.2008.11.026","article-title":"Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination","volume":"75","author":"Inoue","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110781_b0040","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/JTO.0b013e3181b3fee3","article-title":"Management of ground-glass opacity lesions detected in patients with otherwise operable non-small cell lung cancer","volume":"4","author":"Kim","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2025.110781_b0045","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.ejrad.2014.06.023","article-title":"Risk factor analysis of pulmonary hemorrhage complicating CT-guided lung biopsy in coaxial and non-coaxial core biopsy techniques in 650 patients","volume":"83","author":"Nour-Eldin","year":"2014","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.radonc.2025.110781_b0050","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archinte.1997.00440290031002","article-title":"The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules","volume":"157","author":"Swensen","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.radonc.2025.110781_b0055","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1378\/chest.06-1261","article-title":"A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules","volume":"131","author":"Gould","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.radonc.2025.110781_b0060","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.radonc.2025.110781_b0065","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.110781_b0070","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1200\/JCO.2017.74.9671","article-title":"Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline","volume":"36","author":"Schneider","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110781_b0075","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijrobp.2020.01.018","article-title":"To Biopsy or Not to Biopsy?: A Matched Cohort Analysis of Early-Stage Lung Cancer Treated with Stereotactic Radiation with or Without Histologic Confirmation","volume":"107","author":"Dautruche","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110781_b0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13014-023-02229-0","article-title":"Comparison of long-term outcomes of stereotactic body radiotherapy (SBRT) via Helical tomotherapy for early-stage lung cancer with or without pathological proof","volume":"18","author":"Fan","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110781_b0085","article-title":"A propensity-matched analysis of survival of clinically diagnosed early-stage lung cancer and biopsy-proven early-stage non-small cell lung cancer following stereotactic ablative radiotherapy","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.110781_b0090","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lungcan.2012.01.006","article-title":"Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: comparison with non-small-cell lung cancer","volume":"77","author":"Takeda","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2025.110781_b0095","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1378\/chest.13-2924","article-title":"When is a biopsy-proven diagnosis necessary before stereotactic ablative radiotherapy for lung cancer?: A decision analysis","volume":"146","author":"Louie","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.radonc.2025.110781_b0100","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jtho.2016.03.024","article-title":"Absence of Pathological Proof of Cancer Associated with Improved Outcomes in Early-Stage Lung Cancer","volume":"11","author":"Shaikh","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2025.110781_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109817","article-title":"Reirradiation with stereotactic body radiotherapy for primary or secondary lung malignancies: Tumor control probability and safety analyses","volume":"187","author":"Wang","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110781_b0110","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1111\/cas.14185","article-title":"Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer","volume":"110","author":"Meng","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.radonc.2025.110781_b0115","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ijrobp.2024.03.050","article-title":"Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET)","volume":"120","author":"Giuliani","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110781_b0120","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jtho.2021.03.019","article-title":"The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy","volume":"16","author":"Lindberg","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2025.110781_b0125","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ijrobp.2010.07.1977","article-title":"Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus","volume":"81","author":"Kong","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110781_b0130","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.ijrobp.2008.11.019","article-title":"Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer","volume":"73","author":"Xiao","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110781_b0135","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology\/RTOG 0813 Trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110781_b0140","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jtho.2024.05.366","article-title":"Stereotactic Body Radiotherapy for Centrally Located Inoperable Early-Stage NSCLC: EORTC 22113-08113 LungTech Phase II Trial Results","volume":"19","author":"Levy","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2025.110781_b0145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijrobp.2017.09.035","article-title":"Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer","volume":"100","author":"Ronden","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110781_b0150","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-11-2097","article-title":"The use and interpretation of competing risks regression models","volume":"18","author":"Dignam","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2025.110781_b0155","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1158\/1078-0432.CCR-12-0455","article-title":"Competing risk analyses: how are they different and why should you care?","volume":"18","author":"Chappell","year":"2012","journal-title":"Clin Cancer Res : Off J Am Associat Cancer Res"},{"key":"10.1016\/j.radonc.2025.110781_b0160","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/jama.2019.21558","article-title":"Using propensity score methods to create target populations in observational clinical research","volume":"323","author":"Thomas","year":"2020","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.radonc.2025.110781_b0165","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1470-2045(23)00170-5","article-title":"Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis","volume":"24","author":"Zlotta","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.110781_b0170","doi-asserted-by":"crossref","first-page":"S422","DOI":"10.1097\/01.JTO.0000283319.70915.08","article-title":"PD1-3-5: Evaluation of resected tumors that were not diagnosed histologically but were suspected of lung cancer preoperatively","volume":"2","author":"Sawada","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2025.110781_b0175","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1056\/NEJMoa1214726","article-title":"Probability of cancer in pulmonary nodules detected on first screening CT","volume":"369","author":"McWilliams","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2025.110781_b0180","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1378\/chest.128.4.2490","article-title":"Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography","volume":"128","author":"Herder","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.radonc.2025.110781_b0185","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/cncr.31020","article-title":"Probability of cancer in high-risk patients predicted by the protein-based lung cancer biomarker panel in China: LCBP study","volume":"124","author":"Yang","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2025.110781_b0190","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.radonc.2011.09.017","article-title":"Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven disease","volume":"101","author":"Verstegen","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110781_b0195","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1390","article-title":"Association of long-term outcomes and survival with multidisciplinary salvage treatment for local and regional recurrence after stereotactic ablative radiotherapy for early-stage lung cancer","volume":"1","author":"Brooks","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.radonc.2025.110781_b0200","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.radonc.2018.10.017","article-title":"Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis","volume":"132","author":"Kann","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110781_b0205","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.lungcan.2019.02.023","article-title":"Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall: A National Cancer Database Analysis","volume":"130","author":"Foster","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2025.110781_b0210","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ijrobp.2023.12.018","article-title":"Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation Trial","volume":"119","author":"Rimner","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110781_b0215","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1007\/s12094-017-1694-2","article-title":"Comparative efficacy and toxicity of induction chemotherapy with concurrent stereotactic body radiotherapy and stereotactic body radiotherapy with subsequent chemotherapy in patients with clinical stage T1-3N0M0 non-small cell lung carcinoma","volume":"19","author":"Sun","year":"2017","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.radonc.2025.110781_b0220","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.3390\/cancers14133144","article-title":"Rationale for combing stereotactic body radiation therapy with immune checkpoint inhibitors in medically inoperable early-stage non-small cell lung cancer","volume":"14","author":"Chi","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2025.110781_b0225","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jtho.2018.11.018","article-title":"Adjuvant systemic therapy in patients with early-stage NSCLC treated with stereotactic body radiation therapy","volume":"14","author":"Ernani","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2025.110781_b0230","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1748-717X-7-102","article-title":"Image-guided robotic stereotactic radiation therapy with fiducial-free tumor tracking for lung cancer","volume":"7","author":"Bibault","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110781_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110179","article-title":"Deep match: A zero-shot framework for improved fiducial-free respiratory motion tracking","volume":"194","author":"Xu","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110781_b0240","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/1759-7714.12174","article-title":"Influence of different image-guided tracking methods upon the local efficacy of CyberKnife treatment in lung tumors","volume":"6","author":"Guo","year":"2015","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.radonc.2025.110781_b0245","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.21037\/jtd-22-1245","article-title":"CyberKnife\u00ae stereotactic radiation therapy for stage I lung cancer and pulmonary oligometastases: is fiducial implantation still relevant?-a cohort study","volume":"15","author":"Oudin","year":"2023","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.radonc.2025.110781_b0250","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ejrad.2014.01.006","article-title":"CT-guided core biopsy and percutaneous fiducial seed placement in the lung: can these procedures be combined without an increase in complication rate or decrease in technical success?","volume":"83","author":"Mendiratta-Lala","year":"2014","journal-title":"Eur J Radiol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025000763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025000763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:48:34Z","timestamp":1774417714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025000763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":50,"alternative-id":["S0167814025000763"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110781","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk-adapted stereotactic body radiation therapy for the treatment of large (>3\u00a0cm) primary lung cancer with or without histologic confirmation: A propensity score matched and weighted analysis","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110781"}}